Adaptive Biotechnologies Corp - Common Stock (ADPT)

CUSIP: 00650F109

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock
Shares outstanding
151,803,139
Total 13F shares
148,655,164
Share change
+6,206,626
Total reported value
$538,029,201
Put/Call ratio
667%
Price per share
$3.62
Number of holders
173
Value change
+$26,127,842
Number of buys
89
Number of sells
81

Quarterly Holders Quick Answers

What is CUSIP 00650F109?
CUSIP 00650F109 identifies ADPT - Adaptive Biotechnologies Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ADPT - Adaptive Biotechnologies Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VIKING GLOBAL INVESTORS LP
13F
Company
20%
29,993,708
$96,279,803 31 Mar 2024
13F
VANGUARD GROUP INC
13F
Company
8.5%
12,869,818
$41,312,115 31 Mar 2024
13F
Matrix Capital Management Company, LP
13F
Company
7.6%
11,572,590
$37,148,014 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
7.4%
11,190,119
$35,920,282 31 Mar 2024
13F
ARK Investment Management LLC
13F
Company
7%
10,561,296
$33,901,759 31 Mar 2024
13F
Rubric Capital Management LP
13F
Company
6.9%
10,500,000
$33,705,000 31 Mar 2024
13F
Sumitomo Mitsui Trust Group, Inc.
13F
Company
4.1%
6,176,707
$19,827,229 31 Mar 2024
13F
Amova Asset Management Americas, Inc.
13F
Company
4.1%
6,176,707
$19,765,462 31 Mar 2024
13F
Pictet Asset Management Holding SA
13F
Company
2.3%
3,500,964
$10,679,980 31 Mar 2024
13F
Aristotle Atlantic Partners, LLC
13F
Company
2%
2,992,563
$9,606,127 31 Mar 2024
13F
STATE STREET CORP
13F
Company
1.8%
2,680,546
$8,604,553 31 Mar 2024
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
1.7%
2,592,318
$8,321,341 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.7%
2,579,126
$8,279,968 31 Mar 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.1%
1,743,616
$5,597,007 31 Mar 2024
13F
Blue Water Life Science Advisors, LP
13F
Company
1.1%
1,687,665
$5,417,405 31 Mar 2024
13F
BRAIDWELL LP
13F
Company
0.89%
1,357,490
$4,357,543 31 Mar 2024
13F
FEDERATED HERMES, INC.
13F
Company
0.86%
1,301,717
$4,178,512 31 Mar 2024
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
0.82%
1,245,111
$3,996,806 31 Mar 2024
13F
Pier Capital, LLC
13F
Company
0.73%
1,103,441
$3,542,046 31 Mar 2024
13F
Aberdeen Group plc
13F
Company
0.68%
1,029,447
$3,304,525 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
0.67%
1,024,131
$3,287,462 31 Mar 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.57%
869,782
$2,792,000 31 Mar 2024
13F
NORDEA INVESTMENT MANAGEMENT AB
13F
Company
0.57%
859,214
$2,758,077 31 Mar 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.56%
846,379
$2,716,876 31 Mar 2024
13F
Assenagon Asset Management S.A.
13F
Company
0.56%
844,852
$2,711,975 31 Mar 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.55%
835,761
$2,682,793 31 Mar 2024
13F
DDD Partners, LLC
13F
Company
0.49%
739,739
$2,374,562 31 Mar 2024
13F
Cerity Partners LLC
13F
Company
0.45%
676,244
$2,170,742 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
0.44%
669,130
$2,147,911 31 Mar 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.41%
626,721
$2,011,775 31 Mar 2024
13F
Newtyn Management, LLC
13F
Company
0.41%
623,690
$2,002,045 31 Mar 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.4%
604,506
$1,940,465 31 Mar 2024
13F
Tycho Peterson
3/4/5
Chief Financial Officer
mixed-class rows
979,421
mixed-class rows
$1,828,542 04 Mar 2024
Nuveen Asset Management, LLC
13F
Company
0.36%
553,761
$1,777,573 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.34%
517,272
$1,660,443 31 Mar 2024
13F
Bank of New York Mellon Corp
13F
Company
0.26%
395,344
$1,269,053 31 Mar 2024
13F
PEREGRINE CAPITAL MANAGEMENT LLC
13F
Company
0.25%
375,716
$1,206,048 31 Mar 2024
13F
ESSEX INVESTMENT MANAGEMENT CO LLC
13F
Company
0.18%
277,096
$889,478 31 Mar 2024
13F
Nitin Sood
3/4/5
Chief Commercial Officer, MRD
class O/S missing
214,808
$887,157 07 Aug 2023
Point72 Asset Management, L.P.
13F
Company
0.18%
274,700
$881,787 31 Mar 2024
13F
Tejara Capital Ltd
13F
Company
0.18%
269,014
$863,535 31 Mar 2024
13F
R. Mark Adams
3/4/5
Chief Operating Officer
class O/S missing
175,361
$724,241 10 Apr 2023
PDT Partners, LLC
13F
Company
0.14%
215,004
$690,163 31 Mar 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.14%
213,507
$685,357 31 Mar 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.13%
203,941
$654,651 31 Mar 2024
13F
Swiss National Bank
13F
Company
0.13%
199,600
$640,716 31 Mar 2024
13F
Jump Financial, LLC
13F
Company
0.12%
184,779
$593,141 31 Mar 2024
13F
Robertson Stephens Wealth Management, LLC
13F
Company
0.12%
183,786
$589,953 31 Mar 2024
13F
Man Group plc
13F
Company
0.12%
178,007
$571,402 31 Mar 2024
13F
LAZARD ASSET MANAGEMENT LLC
13F
Company
0.12%
175,821
$564,000 31 Mar 2024
13F

Institutional Holders of Adaptive Biotechnologies Corp - Common Stock (ADPT) as of Q2 2024

As of 30 Jun 2024, Adaptive Biotechnologies Corp - Common Stock (ADPT) was held by 173 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 148,655,164 shares. The largest 10 holders included VIKING GLOBAL INVESTORS LP, Rubric Capital Management LP, BlackRock Inc., Matrix Capital Management Company, LP, ARK Investment Management LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., and MASSACHUSETTS FINANCIAL SERVICES CO /MA/. This page lists 173 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
186
Q2 2024 holders
173
Holder diff
-13
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.